Back to search

Article

MEX3A is a new diagnostic, independent prognostic biomarker and a promising therapeutic target in gliomas

2024-05-13

Abstract excerpt

<title>Abstract</title> <p>Gliomas are the most common malignant brain tumors with a dismal prognosis. Despite the progress in defining molecular features, no therapies targeting the known biomarkers significantly increase the survival rate of glioma patients. Recently, it has been demonstrated that high expression of Muscle Excess 3A (MEX3A) in gliomas correlates with poor overall survival (OS), yet its clinical...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
48b0fb9f-6111-5985-84e6-6c539e201822
DOI
10.21203/rs.3.rs-4350316/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
MEX3A is a new diagnostic, independent prognostic biomarker and a promising therapeutic target in gliomasDOI 10.21203/rs.3.rs-4350316/v1
Select a neighboring publication to make it the new centre.